Mini Review
Published on 25 May 2022
Fibrillary Glomerulonephritis and Monoclonal Gammopathy: Potential Diagnostic Challenges
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.880923
- 2,817 views
Type at least 3 characters
1,550 articles
Articles
Original Research
Published on 24 May 2022
Childhood Acute B-Lineage Lymphoblastic Leukemia With CDKN2A/B Deletion Is a Distinct Entity With Adverse Genetic Features and Poor Clinical Outcomes
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.878098
- 2,496 views
- 4 citations
Original Research
Published on 23 May 2022
The Prognostic Utility of 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Analyses of Metabolic Response Rates in Newly Diagnosed Diffuse Large B Cell Lymphoma Patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.772773
- 1,217 views
- 2 citations
Review
Published on 23 May 2022
Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.889034
- 3,040 views
- 5 citations
Review
Published on 19 May 2022
Cellular and Molecular Biomarkers Predictive of Response to Immunotherapy in Acute Myeloid Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.826768
- 2,592 views
- 5 citations
Original Research
Published on 18 May 2022
Prognostic Significance of the Stage at Which an MRD-Negative Status Is Achieved for Patients With Multiple Myeloma Who Received ASCT
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.776920
- 2,081 views
- 1 citation
Brief Research Report
Published on 18 May 2022
The Utility of Euroflow MRD Assessment in Real-World Multiple Myeloma Practice
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.820605
- 2,661 views
- 3 citations
Clinical Trial
Published on 16 May 2022
Clinical Outcomes of BCMA CAR-T Cells in a Multiple Myeloma Patient With Central Nervous System Invasion
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.854448
- 4,126 views
- 4 citations
Review
Published on 13 May 2022
Intersection Between Large Granular Lymphocyte Leukemia and Rheumatoid Arthritis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.869205
- 7,077 views
- 6 citations
Case Report
Published on 13 May 2022
Case Report: Intravascular Large B-Cell Lymphoma: A Clinicopathologic Study of Four Cases With Review of Additional 331 Cases in the Literature
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.883141
- 3,173 views
- 5 citations
Original Research
Published on 13 May 2022
NIPA (Nuclear Interaction Partner of ALK) Is Crucial for Effective NPM-ALK Mediated Lymphomagenesis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.875117
- 1,621 views
Original Research
Published on 13 May 2022
An Extended Prognostic Index of the ISSWM Score Based on Thyroid Complications in Waldenström Macroglobulinemia/Lymphoplasmacytoid Lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.870258
- 1,635 views
- 1 citation
Original Research
Published on 12 May 2022
Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.874462
- 4,004 views
- 5 citations
Original Research
Published on 12 May 2022
Nrf2 Overexpression Decreases Vincristine Chemotherapy Sensitivity Through the PI3K-AKT Pathway in Adult B-Cell Acute Lymphoblastic Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.876556
- 1,846 views
- 3 citations
Original Research
Published on 12 May 2022
Distinct Age-Related Clinical Features and Risk Assessment in Chinese With Chronic Lymphocytic Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.885150
- 2,094 views
- 6 citations
Systematic Review
Published on 11 May 2022
First-Line Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: A Systematic Analysis and Treatment Recommendation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.881346
- 3,617 views